Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment.
Edwards J, Wilmott JS, Madore J, Gide TN, Quek C, Tasker A, Ferguson A, Chen J, Hewavisenti R, Hersey P, Gebhardt T, Weninger W, Britton WJ, Saw RPM, Thompson JF, Menzies AM, Long GV, Scolyer RA, Palendira U. Edwards J, et al. Among authors: palendira u. Clin Cancer Res. 2018 Jul 1;24(13):3036-3045. doi: 10.1158/1078-0432.CCR-17-2257. Epub 2018 Mar 29. Clin Cancer Res. 2018. PMID: 29599411
A proinflammatory CD4+ T cell phenotype in gestational diabetes mellitus.
Sheu A, Chan Y, Ferguson A, Bakhtyari MB, Hawke W, White C, Chan YF, Bertolino PJ, Woon HG, Palendira U, Sierro F, Lau SM. Sheu A, et al. Among authors: palendira u. Diabetologia. 2018 Jul;61(7):1633-1643. doi: 10.1007/s00125-018-4615-1. Epub 2018 Apr 24. Diabetologia. 2018. PMID: 29691600
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials.
Edwards J, Tasker A, Pires da Silva I, Quek C, Batten M, Ferguson A, Allen R, Allanson B, Saw RPM, Thompson JF, Menzies AM, Palendira U, Wilmott JS, Long GV, Scolyer RA. Edwards J, et al. Among authors: palendira u. Clin Cancer Res. 2019 Jun 1;25(11):3247-3258. doi: 10.1158/1078-0432.CCR-18-4011. Epub 2019 Feb 18. Clin Cancer Res. 2019. PMID: 30777877
Novel Immune Targets in Melanoma-Response.
Edwards J, Batten M, Ferguson A, Palendira U, Wilmott JS, Long GV, Scolyer RA. Edwards J, et al. Among authors: palendira u. Clin Cancer Res. 2019 Sep 1;25(17):5424-5425. doi: 10.1158/1078-0432.CCR-19-1866. Clin Cancer Res. 2019. PMID: 31481485 No abstract available.
Tissue-resident regulatory T cells accumulate at human barrier lymphoid organs.
Hewavisenti RV, Ferguson AL, Gasparini G, Ohashi T, Braun A, Watkins TS, Miles JJ, Elliott M, Sierro F, Feng CG, Britton WJ, Gebhardt T, Tangye S, Palendira U. Hewavisenti RV, et al. Among authors: palendira u. Immunol Cell Biol. 2021 Sep;99(8):894-906. doi: 10.1111/imcb.12481. Epub 2021 Jul 27. Immunol Cell Biol. 2021. PMID: 34080230
A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection.
Counoupas C, Johansen MD, Stella AO, Nguyen DH, Ferguson AL, Aggarwal A, Bhattacharyya ND, Grey A, Hutchings O, Patel K, Siddiquee R, Stewart EL, Feng CG, Hansbro NG, Palendira U, Steain MC, Saunders BM, Low JKK, Mackay JP, Kelleher AD, Britton WJ, Turville SG, Hansbro PM, Triccas JA. Counoupas C, et al. Among authors: palendira u. NPJ Vaccines. 2021 Nov 30;6(1):143. doi: 10.1038/s41541-021-00406-4. NPJ Vaccines. 2021. PMID: 34848711 Free PMC article.
64 results